DEF: ParkerVision Sets 2025 Annual Shareholder Meeting Agenda

Sentiment:

Proxy Statement 18 August 2025 4:04 PM

ParkerVision, Inc. announced its 2025 Annual Meeting of Shareholders to be held virtually on September 30, 2025, focusing on director elections, auditor ratification, and executive compensation votes.

Delay expectedIn January 2025, the compensation committee delayed its annual non-employee director compensation awards pending review of the Alliant report on independent director compensation.

Capital raiseThe company has sold convertible notes to accredited investors, including certain directors, from time to time.Director Lewis Titterton purchased an aggregate of $425,000 in convertible notes from the company between 2018 and 2022, with conversion prices ranging from $0.10 to $0.40 per share.Director Paul Rosenbaum purchased a new $100,000 note in September 2023 and an additional $100,000 in promissory notes in May 2022.Former director Sanford Litvack purchased $25,000 in promissory notes in August 2022 and 62,500 shares in a private placement transaction in January 2023.The company has a note payable to Sterne, Kessler, Goldstein & Fox, PLLC (the law firm where director Robert Sterne is a partner) with an outstanding balance of approximately $0.3 million at December 31, 2024.

Worse than expectedThe company's net income for 2024 was a loss of $(14,472) thousand, following a loss in 2022, indicating a return to unprofitability after a brief positive net income in 2023.The Total Shareholder Return (TSR) for a $100 investment declined to $17.39 in 2023 and, despite a recovery, remained below the initial $100 at $95.38 in 2024, suggesting poor shareholder value creation over the period.The prior independent registered public accounting firm (MSL, P.A.) included an explanatory paragraph regarding the company's ability to continue as a 'going concern' in their audit report for the year ended December 31, 2023, which is a serious red flag concerning financial viability.

Summary

The 2025 Annual Meeting of Shareholders for ParkerVision, Inc. will be held virtually on September 30, 2025, at 11:00 a.m. Eastern Time.
Shareholders will vote on the election of two Class III directors (Paul A. Rosenbaum and Robert G. Sterne) to serve until 2028.
A proposal to ratify the selection of Frazier & Deeter, LLC as the company's independent registered public accounting firm for the year ending December 31, 2025, will be presented.
Shareholders will cast advisory votes on named executive officer compensation ('Say on Pay') and the frequency of future Say on Pay votes, with the Board recommending a two-year frequency.
The record date for shareholders entitled to vote at the Annual Meeting is August 4, 2025, with 120,116,916 shares of common stock outstanding.
Proxy materials and the annual report will be available on or about August 18, 2025.

Sentiment

Score: 3

Explanation: The filing reveals significant financial challenges, including a 'going concern' qualification from the previous auditor and negative net income in 2024, alongside a poor Total Shareholder Return over the past few years. While management has taken steps like cost reduction and executive compensation adjustments, the underlying financial health appears precarious.

Positives

The Board maintains corporate governance policies and practices that reflect what it believes are best practices, including following Nasdaq rules for director independence despite being on OTCQB.
Executive officers received significant discretionary cash bonuses for fiscal year 2024 ($350,000 for CEO, $100,000 for CFO) in recognition of their contributions to strategic initiatives, patent litigation efforts, financial stability, and cost reduction.
Base salaries for the CEO and CFO were increased in April 2025 (CEO to $400,000, CFO to $250,000), partially offsetting prior voluntary reductions and aiming to appropriately compensate executives, though still below the 50th percentile of a peer group.
The compensation committee engaged an independent consultant (Alliant Human Capital) in December 2024 to evaluate executive and non-employee director compensation programs, indicating a commitment to competitive and fair compensation practices.

Negatives

The company reported a net loss of $(14,472) thousand for the fiscal year ended December 31, 2024, following a net loss in 2022, indicating a return to unprofitability.
The Total Shareholder Return (TSR) for a $100 fixed investment declined to $17.39 by year-end 2023 and, despite a recovery, remained below the initial $100 at $95.38 by year-end 2024, indicating poor shareholder value creation over the period.
The prior independent registered public accounting firm, MSL, P.A., included an explanatory paragraph in their audit report for the year ended December 31, 2023, regarding the company's ability to continue as a 'going concern'.

Risks

The company's ability to continue as a 'going concern' was highlighted by the previous independent registered public accounting firm in their audit report for the year ended December 31, 2023, indicating significant financial viability concerns.
The company's strategic initiatives and executive compensation are tied to 'patent litigation efforts,' suggesting a reliance on legal outcomes for business success, which can be inherently uncertain and costly.
The company has incurred net losses in two of the last three fiscal years (2022 and 2024), indicating ongoing challenges in achieving sustained profitability.

Future Outlook

The filing primarily focuses on past compensation and upcoming shareholder votes, with limited explicit forward-looking business guidance. It indicates the compensation committee's intent to appropriately compensate executives for their leadership and sustained commitment to advancing company goals. The Board also plans to periodically reassess the frequency of Say on Pay votes based on shareholder feedback and company circumstances.

Management Comments

The Board believes that combining the roles of Chief Executive Officer and Chairman of the Board promotes leadership and direction for the Board and for executive management, as well as allowing for a single, clear focus for the chain of command.
Mr. Parker's leadership, in both his Chairman of the Board and Chief Executive Officer roles, continues to ensure that we remain dedicated to and focused on both our short and long-term objectives.
The bonuses reflect the compensation committee's intent to appropriately compensate these executives for their leadership and sustained commitment to advancing the Company's goals.

Industry Context

This filing is a standard proxy statement for an annual shareholder meeting, providing insights into corporate governance, executive compensation, and financial oversight. The company's emphasis on 'patent litigation efforts' and 'disruptive technologies' suggests its operations are within a technology or intellectual property-driven sector. The 'going concern' note from the previous auditor indicates significant financial challenges, which could be company-specific or reflective of broader pressures within its niche, potentially impacting its ability to compete or innovate effectively.

Comparison to Industry Standards

Executive base compensation for the named executive officers (CEO and CFO) was established below the 50th percentile when compared to a similarly sized peer group, suggesting a conservative approach to base pay relative to industry peers.
The company adheres to Nasdaq Stock Market rules for determining director independence, despite being quoted on the OTCQB Venture Market, indicating a commitment to higher corporate governance standards than typically required for its listing tier.
The inclusion of an explanatory paragraph regarding the company's ability to continue as a 'going concern' by the prior independent registered public accounting firm for the 2023 financial statements is a significant deviation from standard audit reports and indicates a heightened level of financial risk compared to financially stable companies in any industry.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Class I Director	Sanford M. Litvack	N/A	April 2025	Resignation, leading to a reduction of the Board size from five to four members.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Size Reduction	Following the resignation of Sanford M. Litvack, the Board reduced its size from five to four members, determining it appropriate given the size of operations.	April 2025	A smaller board may streamline decision-making but could reduce diversity of perspectives or increase workload for remaining directors.
Executive Compensation Policy	Approved increases in base compensation for the CEO (from $260,000 to $400,000) and CFO (from $180,000 to $250,000) in April 2025, partially offsetting prior voluntary reductions and aligning with strategic contributions.	April 2025	Aims to better compensate executives for their contributions and leadership, potentially improving retention and motivation, though still below the 50th percentile of a peer group.
Equity Award Modification	Modified nonqualified options for the CEO (8,000,000 options) and CFO (1,000,000 options) to extend the expiration date from January 11, 2026, to January 11, 2031, resulting in a one-time charge of approximately $1.9 million.	April 2025	Extends the incentive period for key executives, potentially aligning their long-term interests with shareholder value, but incurs a significant accounting charge.
Independent Auditor Change	MSL, P.A. ceased services as the independent registered public accounting firm on November 1, 2024, due to a transaction with Forvis Mazars, LLP. Frazier & Deeter, LLC was appointed on November 12, 2024, for the year ending December 31, 2024.	November 2024	A change in auditors can be disruptive but was necessitated by MSL's corporate transaction. The new firm's appointment ensures continuity of audit services, but the prior auditor's 'going concern' note remains relevant.

Legal Proceedings

Management's statements mention the CEO's leadership in overseeing 'patent litigation efforts,' indicating ongoing legal activities related to patents.
Robert G. Sterne, a director, is a partner at Sterne, Kessler, Goldstein & Fox PLLC, a law firm specializing in patent and intellectual property law, which provides legal services to the company, further indicating active engagement in patent-related legal matters.

Related Party Transactions

Lewis Titterton (director): Purchased $425,000 in convertible notes (2018-2022), repaid $100,000 in September 2023, amended notes in May 2024 (extended maturity, reduced interest, deferred payment), converted $125,000 in September 2024, and converted remaining $200,000 in May 2025.
Paul Rosenbaum (director): Repaid a $100,000 note in September 2023, purchased a new $100,000 note in September 2023, purchased $100,000 in promissory notes in May 2022, amended notes in May 2024 (deferred interest), and converted all outstanding notes in October 2024.
Sanford Litvack (former director): Purchased $25,000 in promissory notes in August 2022, amended the note in May 2024 (deferred interest), with $25,000 outstanding at December 31, 2024, maturing August 2027. He also purchased 62,500 shares in a private placement in January 2023.
Sterne, Kessler, Goldstein & Fox, PLLC (law firm where director Robert Sterne is a partner): Received approximately $39,000 in 2024 and $52,000 in 2023 for patent-related legal services. The company also paid approximately $150,000 in 2024 and $163,000 in 2023 for principal and interest on a 2016 note payable to the firm, with an outstanding balance of approximately $0.3 million at December 31, 2024.

Stakeholder Impact

Shareholders: Will participate in key corporate governance decisions, including director elections, auditor ratification, and executive compensation votes. The 'going concern' note and negative TSR indicate potential risk to shareholder value. Related party transactions involving directors as noteholders could raise questions about potential conflicts of interest, though the audit committee reviews them.
Employees: Executive officers received bonuses and salary increases, partially offsetting prior voluntary reductions, which could boost morale among leadership. Non-compete agreements are in place for all employees.
Creditors: The company has outstanding convertible notes and a note payable to a law firm, indicating ongoing debt obligations. The 'going concern' note from the previous auditor would be a significant concern for creditors regarding the company's ability to meet its financial obligations.
Auditors: The company experienced a change in its independent registered public accounting firm from MSL, P.A. to Frazier & Deeter, LLC, due to MSL's corporate transaction, ensuring continuity of audit services.

Next Steps

Shareholders will vote on the election of two Class III directors (Paul A. Rosenbaum and Robert G. Sterne) at the Annual Meeting.
Shareholders will vote on the ratification of Frazier & Deeter, LLC as the independent registered public accounting firm for 2025.
Shareholders will cast advisory votes on named executive officer compensation and the frequency of future Say on Pay votes.
The 2025 Annual Meeting of Shareholders will be held virtually on September 30, 2025.
The Board will periodically reassess the frequency of Say on Pay votes based on shareholder feedback and company circumstances.
Shareholders may submit proposals for the 2026 proxy statement by June 2, 2026 (SEC rules) or April 20, 2026 (bylaws).
Shareholders intending to solicit proxies for director nominees must provide notice by August 1, 2026.

Key Dates

Date	Description
August 1989	Company inception; Jeffrey Parker became Chairman of the Board and Chief Executive Officer.
March 1994	Cynthia French became Controller and Chief Accounting Officer.
February 2000	Robert Sterne first served as a director.
June 2003	Robert Sterne's first directorship ended.
June 2004	Cynthia French became Chief Financial Officer.
September 2006	Robert Sterne rejoined the Board as a director.
August 2007	Cynthia French became Corporate Secretary.
September 2018	Voluntary 20% base salary reductions for named executive officers implemented; Paul Rosenbaum joined the audit committee; Lewis Titterton joined the Board and audit committee.
April 2019	Lewis Titterton resigned from the Board.
September 2019	MSL, P.A. became the company's principal accountants.
January 11, 2021	Original grant date for 8,000,000 options awarded to CEO and 1,000,000 options awarded to CFO, with an original expiration date of January 11, 2026.
May 2022	Paul Rosenbaum purchased an additional $100,000 in promissory notes.
August 2022	Sanford Litvack purchased $25,000 in promissory notes.
January 2023	Sanford Litvack purchased 62,500 shares in a private placement transaction.
April 2023	Paul Rosenbaum joined the compensation committee.
June 2023	Lewis Titterton rejoined the Board.
September 2023	Company repaid Mr. Titterton $100,000 upon maturity of a note; company repaid Mr. Rosenbaum $100,000 upon maturity of a note; Mr. Rosenbaum purchased a new $100,000 note.
November 2023	Lewis Titterton became a member of the audit and compensation committees.
February 1, 2024	Non-employee directors were awarded 275,000 five-year nonqualified stock options.
May 1, 2024	First quarterly vesting increment for non-employee director options awarded on February 1, 2024.
May 10, 2024	Amended convertible notes held by Mr. Titterton, Mr. Rosenbaum, and Mr. Litvack to defer interest payments or extend maturity dates.
September 2024	Mr. Titterton converted an aggregate of $125,000 in notes into common stock.
October 2024	Mr. Rosenbaum converted all of his outstanding notes into common stock.
November 1, 2024	MSL, P.A. notified the Audit Committee and management that it would cease services as the independent registered public accounting firm.
November 7, 2024	Current Report on Form 8-K filed regarding the change in independent registered public accounting firm.
November 8, 2024	Amended Current Report on Form 8-K filed.
November 12, 2024	Audit Committee approved the appointment of Frazier & Deeter, LLC as the independent registered public accounting firm for the year ending December 31, 2024.
December 16, 2024	Frazier & Deeter, LLC completed its client acceptance procedures and accepted its appointment.
December 17, 2024	Audit Committee executed an engagement letter with Frazier & Deeter, LLC.
December 23, 2024	Current Report on Form 8-K filed regarding the appointment of Frazier & Deeter, LLC.
December 31, 2024	Fiscal year end for which financial statements were audited and compensation reported.
January 2025	Compensation committee delayed annual non-employee director compensation awards; approved payment of discretionary cash bonuses for fiscal year 2024 performance to executive officers.
April 2025	Sanford M. Litvack resigned as a Class I director; Board size reduced to four members; Compensation committee approved increases in base compensation for CEO and CFO; Modified nonqualified options held by named executive officers to extend expiration date.
May 2025	Mr. Titterton converted his remaining $200,000 outstanding convertible note into common stock.
July 3, 2025	Non-employee directors were awarded 2025 director compensation (RSUs or nonqualified options).
August 4, 2025	Record date for determination of shareholders entitled to notice of, and to vote at, the Annual Meeting.
August 18, 2025	Company's proxy statement and annual report to security holders will be available on or about this date.
September 30, 2025	Date of the 2025 Annual Meeting of Shareholders.
January 11, 2026	Extended expiration date for modified nonqualified options held by named executive officers.
March 2026	Maturity date for certain amended convertible notes held by Mr. Titterton and Mr. Rosenbaum's new note.
April 20, 2026	Deadline for shareholder proposals or director nominations for the 2026 annual meeting under company bylaws.
June 2, 2026	Deadline for shareholder proposals for possible inclusion in the 2026 proxy statement under SEC Rule 14a-8.
August 1, 2026	Deadline for shareholders to provide notice for soliciting proxies in support of director nominees for the 2026 annual meeting under Rule 14a-19.
August 2027	Maturity date for outstanding convertible notes held by Mr. Litvack.
May 2027	Maturity date for certain amended convertible notes held by Mr. Titterton.
2028	Term end for Class III directors elected at the 2025 Annual Meeting.
February 1, 2029	Expiration date for nonqualified stock options awarded to non-employee directors on February 1, 2024.
January 11, 2031	Extended expiration date for modified nonqualified options held by named executive officers.

Recommendation

sell

The filing reveals a 'going concern' explanatory paragraph from the previous auditor for the 2023 financial statements, indicating substantial doubt about the company's ability to continue operations. This is a critical red flag. Furthermore, the company reported a net loss in 2024 and its Total Shareholder Return has been significantly negative over the past few years, demonstrating a consistent inability to generate shareholder value. While executive compensation adjustments and strategic efforts are noted, the fundamental financial health appears highly precarious, making the stock a high-risk investment with significant downside potential.

Keywords

ParkerVision, PRKR, SEC filing, proxy statement, annual meeting, corporate governance, executive compensation, director election, audit firm, shareholder vote, patent litigation, financial reporting, going concern, related party transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.